Harvard Business Review

SEPTEMBER 23, 2014

I often hear this question when I visit companies and speak about how to make an innovative idea less terrifying to high level executives. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so. And yet management sponsorship is crucial for any ambitious initiative.

Innovation 14

Innovation P&L Short-term Company 14

Harvard Business Review

DECEMBER 27, 2016

A simple question was asked: are hospitals ranked more highly when they are led by medically trained doctors or non-MD professional managers? The analysis showed that hospital quality scores are approximately 25% higher in physician-run hospitals than in manager-run hospitals. …and how training can make them even better ones.

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

MAY 8, 2013

Over the past 20 years, no group has endured greater pain and humiliation within organizations than mid-level managers (MLMs — managers from two levels below the CEO down to the line managers). Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 11

Middle Management Management Automotive Pharmaceuticals 11

Harvard Business Review

JUNE 29, 2015

Second, the main goal of PE investors is to increase a firm’s value so that it can be sold for profit. And a recent working paper out of the Dusseldorf Institute for Competition Economics ( DICE ), a think tank of sorts, focuses on the latter by exploring whether leveraged buyouts (LBOs) make firms more innovative.

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

MARCH 18, 2018

In fact, by government edict, the goal is to direct policy, health care, and even citizens themselves toward longer, healthier, more enriching lives. Why the Pharmaceutical Industry Is Booming in Japan. One project is a remote intensive-care patient management program. Read More from the Government of Japan.

Health Care 10

Health Care Industry Pharmaceuticals Content 10

Harvard Business Review

DECEMBER 20, 2011

The Lipitor story seems to be about a managed end: the highly anticipated demise (due to the expiration of its patent last Nov. Apple use life-cycle management to explore a new way to drive the business and business model forward. 30) of a blockbuster prescription drug. But they have fundamentally more in common than meets the eye.

Disintermediation 16

Disintermediation Industry Pharmaceuticals Price 16

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. When predefined treatment goals are attained, both parties contractually benefit. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge.

Health Care 9

Health Care Pharmaceuticals Information Technology Supply Chain 9

Harvard Business Review

FEBRUARY 29, 2016

We then tested the model using quantitative data about the incidence of safety-related errors in the context of pharmaceutical drugs. We analyzed 146 pharmaceutical firms between 1997 and 2004 for a quantitative look at this pattern of learning and forgetting after safety-based errors.

Organization 8

Organization McCombs Pharmaceuticals Learning-by-Doing 8

Harvard Business Review

MAY 22, 2018

Similarly, if you’re addressing a group of newly promoted managers, you can make a point of emphasizing stories about people in that situation, or who have recently reinvented themselves or changed jobs in general.

Audience 13

Audience How To Pharmaceuticals Conference 13

Harvard Business Review

APRIL 2, 2018

We invest billions of dollars each year in medicines, new technologies, doctors, and hospitals—all with the goal of improving health, arguably our most prized commodity. In cases like this, it may be instructive to think about the circumstances through the lens of a portfolio manager who is choosing how to allocate investments.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. The translation involves people and processes.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it''s a wonder we have any innovative products at all. Effective means of boosting innovation already exist, but not enough companies are making use of them. I''ll describe both, but first let''s look at what''s wrong with some of the traditional sources of innovation.

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

SEPTEMBER 15, 2014

A big goal requires a “thick we” network — a community of people who feel responsible for collaborating toward a shared purpose that they see as superseding their individual needs. Consider Ashoka , which provides start-up funding and support for social innovators worldwide. Informal leadership Managing people'

Gilbert 12

Gilbert Participative Cooper Network Economy 12

Harvard Business Review

SEPTEMBER 10, 2013

A good idea faces so many obstacles en route to market today that it’s a wonder we have any innovative products at all. Effective means of boosting innovation already exist, but not enough companies are making use of them. You know those baby sea turtles that get eaten by birds and crabs on their way from the nest to the water?

Venture Capitalist 8

Venture Capitalist Venture Funding Innovation Incentives 8

Harvard Business Review

OCTOBER 13, 2011

Bank marketing materials focus on the dreams, anxieties and goals of consumers. Risk management processes don't — but they should. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Here, the protocols from other industries can provide some insight.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

SEPTEMBER 5, 2016

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. And providers want the flexibility to deliver outcomes in the best, most innovative, and most efficient way possible without being micromanaged by the customer. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

JUNE 20, 2017

For organizations seeking to become more adaptive and innovative, culture change is often the most challenging part of the transformation. Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

JULY 14, 2017

A recent survey on easing racial tensions at work by the Center for Talent Innovation found that “The workplace is one of few settings where we commonly interact across racial and ethnic lines.” Today’s employees seek work not only to make a living but also to achieve meaningful social goals.

Diversity 12

Diversity Politics Survey Incubator 12

Harvard Business Review

JANUARY 24, 2012

Nine years ago, when I launched The Energy Project during an economic boom, it was nearly impossible to find senior leaders open to the idea that demand was exceeding people's capacity, and that it was critical to the bottom line to teach employees new ways to manage their energy more skillfully.

Meyer 15

Meyer Goleman Emotional Intelligence Pharmaceuticals 15

Strategy Driven

MARCH 18, 2011

The goal is balance: A coherent company strikes a balance where the right product and service portfolio naturally thrives within a capabilities system consciously chosen and implemented to support a deliberate strategy or way to play. It’s a ‘sharp pencil’ capabilities system rooted in superior information.

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. In some instances, the end results were firm closures and lost jobs. manufacturers are taking notice.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

APRIL 13, 2012

It's depressing to realize how few of the teams in our lives use their human capital and opportunities well, when it comes to sustaining performance, innovating, or adapting. That's true whether we're talking about families, sports, projects, management, or research. For instance: 1.) Now to the world of business.

Team 17

Team Sports Pharmaceuticals PR 17

Harvard Business Review

MAY 16, 2011

But most true collaborations cannot be controlled with fixed terms that are defined in advance — they must be managed through relational contracts that allow you to respond flexibly to new information. Their challenge then is to learn how to manage these partnerships differently than the vendor relationships they had before.

Software 18

Software Licensing Long-term Telecommunications 18

Harvard Business Review

OCTOBER 13, 2014

By forcing organizations to clearly articulate their goals and then to rigorously judge their decisions by those metrics, experimental tests can help managers avoid costly mistakes and can open up the consideration of other possible solutions. Change management Human resources Operations' The change is a success, right?

Flextime 14

Flextime Call Center Human Resources CRM 14

Harvard Business Review

MARCH 9, 2015

Big data and analytics can make organizations more efficient and agile by empowering middle-level and far-flung managers to make decisions and seize business opportunities that previously required scarce data and executive approval. For example, a study of a multinational pharmaceutical company revealed that leaders in its U.S.

Tools 8

Tools CEO Mezzanine Software 8

Harvard Business Review

DECEMBER 14, 2015

He says he’s seeing a growing interest among leaders in meditation as a way to build leadership skills – and achieve business goals. They want to see how these approaches … are truly beneficial to existing priorities like retention, talent advancement, innovation.” ” Archana says.

CEO 8

CEO Emotional Intelligence Cooper Pharmaceuticals 8

Harvard Business Review

OCTOBER 27, 2014

A mid-level manager in this 5,000-employee hospital, she is leading a 70-member group on patient flow as part of a larger organizational effort. Her ability to lead and inspire — to become a change leader from her position as a mid-level manager — is helping her team produce results. I found a few defining characteristics: 1.

Middle Management 15

Middle Management Six Sigma Taylorism Taylor 15

Harvard Business Review

SEPTEMBER 5, 2016

Yet there’s compelling evidence that bureaucracy creates a significant drag on productivity and organizational resilience and innovation. million managers, first-line supervisors, and administrators in the American workforce in 2014. That works out to one manager and administrator for every 4.7 Here’s the arithmetic.

Cost 8

Cost Bureaucracy GDP Management 8

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. Corporate directors identified talent management as their single greatest strategic challenge. We know that organizations commit enormous resources and effort to talent management, so why aren''t they doing a better job? Not rising costs.

Talent Management 10

Talent Management Company Telecommunications Management 10

Strategy Driven

JANUARY 24, 2011

Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.

Execution 67

Execution Company 360-Degree Feedback Cooper 67

Harvard Business Review

JUNE 23, 2015

As one middle manager told me, “No one was willing to go to management and say, ‘Let’s redeploy everyone, including myself, and do something else because this project isn’t working.'” maintaining alignment with the company’s corporate goals. They fail on at least three of five criteria: 1.)

Team 8

Team Project Software Engineering 8

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. This is an incredible moment for innovation.

Innovation 15

Innovation Productivity Products Venture Capitalist 15

Harvard Business Review

NOVEMBER 3, 2017

The team tasked with overseeing the effort designed an aggressive implementation plan that tied targets to manager compensation. However, beyond the strategic goal of becoming an industry leader in terms of cost structure, there was no “story” for how this effort would complement the business’s broader ambitions.

Execution 15

Execution Strategy Decentralization Short-term 15

Harvard Business Review

MARCH 6, 2015

Mark, a ten-year veteran of the pharmaceutical R&D world with a Ph.D. in statistics, was the obvious choice to lead the SAS software and data management group of a global healthcare corporation when the current director suddenly departed. You and Your Team. Get better at helping your employees stretch and grow.

Management 8

Management Self-aware Teamwork Pharmaceuticals 8

Harvard Business Review

OCTOBER 25, 2018

A history of maximizing pageviews is not itself a compelling reason to set a renewed goal of maximizing pageviews. With a goal and a set of agreed upon assumptions in hand, the organization has everything it needs to start posing KBQs, or lines of inquiry that propel it from “What do we want to achieve? ” Insight Center.

How To 14

How To Pharmaceuticals Process Objective 14

Harvard Business Review

MAY 12, 2011

Instead of a pharmaceutical industry, I see a new set of mental and physical discontents, like rates of suspiciously normally "abnormal" mental illnesses and drugs whose lists of "side effects" are longer than the Magna Carta. Gary Hamel , whose Future of Management is about creating the capacity to live better.

GDP 22

GDP Hamel Industry Construction 22

Harvard Business Review

OCTOBER 8, 2013

Today, payers and providers are using a range of strategies to accomplish this goal, including patient-centered medical homes , value-based contracting , and accountable care organizations (ACOs). Finally, REBP gives payers a way to prepare for the future, when episode-based performance management is likely to be a required capability.

Health Care 9

Health Care Cost Analysis Competitive Advantage 9